2021 ASCO Election - Candidate COI Disclosure Report All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Position being considered for on the Name Last Update of ASCO COI Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Accommodations, Other Relationship (OPTIONAL) (OPTIONAL) Open ballot Disclsoure Ownership Interests Role Intellectual Property Expenses Uncompensated Payments Link President-Elect James L. Abbruzzese 7/10/2020 Bessor Pharma AstraZeneca AstraZeneca E. R. Squibb AstraZeneca Relationships Moleculin Celgene Bessor Pharma Fujifilm Celgene Halozyme Fujifilm Pharmacyte Biotech Halozyme Sun Pharma Moleculin Sun Biopharma
President-Elect Eric P. Winer 9/2/2020 Genentech/Roche Carrick Therapeutics Genentech (Inst) InfiniteMD Genomic Health G1 Therapeutics Genentech/Roche GlaxoSmithKline Jounce Therapeutics Leap Therapeutics Lilly Seattle Genetics Syros Pharmaceuticals
Board of Directors - Designated Melissa S. Dillmon 5/27/2020 Johnson & Johnson (I) Puma Biotechnology Community Oncologist Board of Directors - Designated Gladys I. Rodriguez 7/29/2020 Abbott Laboratories (I) Genentech Puma Biotechnology (Inst) Community Oncologist Merck (I) Novartis
Board of Directors - Designated Medical Primo Lara 8/11/2020 Janssen Aragon Pharmaceuticals Oncologist (Inst) Incyte (Inst) Janssen Biotech (Inst) Merck (Inst) Pharmacyclics (Inst) Taiho Pharmaceutical (Inst) TRACON Pharma (Inst)
Board of Directors - Designated Medical Taofeek K. Owonikoko 7/9/2020 Cambium Oncology Abbvie Abbvie Abbvie (Inst) #OVERCOMING EMD Serono Reflexion Medical Oncologist Amgen Aeglea Biotherapeutics ACQUIRED RESISTANCE Roche/Genentech ARMO BioSciences (Inst) TO CHEMOTHERAPY AstraZeneca Amgen (Inst) TREATMENTS Bayer Astellas Pharma (Inst) THROUGH BerGenBio AstraZeneca/MedImmune SUPPRESSION OF Boehringer Ingelheim (Inst) STAT3 (Inst) Bristol-Myers Squibb Bayer (Inst) #SELECTIVE Celgene Bristol-Myers Squibb (Inst) CHEMOTHERAPY Eisai Celgene (Inst) TREATMENTS AND EMD Serono Corvus Pharmaceuticals DIAGNOSTIC METHODS G1 Therapeutics Fujifilm (Inst) RELATED THERETO (Inst) Heron Pharmaceutical G1 Therapeutics (Inst) #DR4 Modulation and its Lilly Incyte (Inst) Implications in EGFR- Lilly Loxo/Lilly (Inst) Target Cancer Therapy MedImmune Merck (Inst) Ref:18089 PROV (CSP) Merck Novartis (Inst) United States Patent Novartis Pfizer (Inst) Application No. 62/670,210 PharmaMar Regeneron (Inst) June 26, 2018 (Co- Sandoz Stem CentRx (Inst) Inventor) Seattle Genetics United Therapeutics (Inst) (Inst) Takeda #Soluble FAS ligand as a Xcovery biomarker of recurrence in thyroid cancer; provisional patent 61/727,519 (Inventor) (Inst)
Board of Directors - Undesignated Mariana Chavez-Mac Gregor 10/10/2020 MD Anderson Physician’s Eisai AstraZeneca Novartis (Inst) Abbott Laboratories Pfizer Specialty Network Pfizer Novartis Pfizer Roche/Genentech Pfizer asofar Genomic Health
Board of Directors - Undesignated Charles R. Thomas 3/5/2020 AMA AMA Lilly Specialty
Nominating Committee Merry Jennifer Markham 9/24/2020 Aduro Biotech (Inst) Lilly (Inst) Novartis (Inst) Tesaro (Inst) VBL Therapeutics (Inst) Astra Zeneca (Inst) Position being considered for on the Name Last Update of ASCO COI Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Accommodations, Other Relationship (OPTIONAL) (OPTIONAL) Open ballot Disclsoure Ownership Interests Role Intellectual Property Expenses Uncompensated Payments Link Nominating Committee Toni K. Choueiri 10/6/2020 Dana Farber Cancer ASCO Pionyr Alexion Pharmaceuticals Alexion Pharmaceuticals Agensys (Inst) #-International Patent Alexion Pharmaceuticals Medical writing and Relationships Hospital Dana Farber TEMPEST alligent alligent Analysis Group (Inst) Application No. alligent editorial assistance support Cancer Hospital Analysis Group Analysis Group AstraZeneca (Inst) PCT/US2018/058430, Analysis Group may have been funded by KidneyCan ASCO ASCO Bayer (Inst) entitled “Biomarkers of AstraZeneca Communications NCCN AstraZeneca AstraZeneca Bristol-Myers Squibb (Inst) Clinical Response and Bayer companies funded by Bayer Bayer Calithera Biosciences (Inst) Benefit to Immune Bristol-Myers Squibb pharmaceutical companies Bristol-Myers Squibb Bristol-Myers Squibb Celldex (Inst) Checkpoint Inhibitor Cerulean Pharma such as ClinicalThinking, Cerulean Pharma Cerulean Pharma Cerulean Pharma (Inst) Therapy Clinical Care Options Health Clinical Care Options Clinical Care Options Congressionally Directed #International Patent Corvus Pharmaceuticals Interactions, Envision Corvus Pharmaceuticals Corvus Pharmaceuticals Medical Research Application No. Eisai Pharma Group, Fishawack Eisai Eisai Programs (DOD) (Inst) PCT/US2018/12209, EMD Serono Group of Companies, EMD Serono EMD Serono Corvus Pharmaceuticals entitled “PBRM1 ESMO Parexel Exelixis Exelixis (Inst) Biomarkers Predictive of Exelixis Foundation Medicine Foundation Medicine Eisai (Inst) Anti-Immune Checkpoint Foundation Medicine Genentech/Roche GlaxoSmithKline Exelixis (Inst) Response GlaxoSmithKline GlaxoSmithKline Harborside Press Foundation Medicine (Inst) Harborside Press Harborside Press HERON GATEWAY for Cancer HERON HERON Ipsen Research (Inst) Ipsen Ipsen Kidney Cancer Journal GlaxoSmithKline (Inst) Kidney Cancer Journal Kidney Cancer Journal Lancet Oncology Ipsen (Inst) Lancet Oncology Lancet Oncology Lilly Merck (Inst) Lilly Lilly Lpath NCI (Inst) Lpath Lpath Merck Novartis (Inst) Merck Merck Michael J. Hennessy Peloton Therapeutics (Inst) Michael J. Hennessy Michael J. Hennessy Associates Pfizer (Inst) Associates Associates Navinata Healthcare Prometheus (Inst) Navinata Healthcare Navinata Healthcare NCCN Roche (Inst) NCCN NCCN NEJM Roche/Genentech (Inst) NEJM NEJM Novartis Seattle Genetics/Astellas Novartis Novartis Paltform Q (Inst) Peloton Therapeutics Peloton Therapeutics Peloton Therapeutics Takeda (Inst) Pfizer Pfizer Pfizer TRACON Pharma (Inst) PlatformQ Health PlatformQ Health Prometheus Laboratories Prometheus Prometheus Roche/Genentech Roche/Genentech Sanofi/Aventis Sanofi/Aventis Sanofi/Aventis UpToDate UpToDate UpToDate
Nominating Committee Daniel J. George 10/6/2020 Capio Acceleron Pharma Astellas Pharma Bayer Acerta Pharma (Inst) Bayer BioSciences American Association for AstraZeneca Exelixis Astellas Pharma (Inst) Exelixis Cancer Research Bayer Sanofi Bayer (Inst) Janssen Oncology Axess Oncology Bristol-Myers Squibb Bristol-Myers Squibb (Inst) Merck Bayer Exelixis Calithera Biosciences (Inst) Pfizer EMD Serono Genentech Dendreon (Inst) Sanofi Exelixis Innocrin Pharma Exelixis (Inst) UroToday Janssen Oncology Janssen Innocrin Pharma (Inst) Millennium Medical Merck Sharp & Dohme Janssen Oncology (Inst) Publishing Michael J. Hennessy Novartis (Inst) OncLive Associates Pfizer (Inst) Pfizer Myovant Sciences Sanofi/Aventis (Inst) Sanofi Pfizer UroToday Sanofi Vizuri Health Sciences, LLC Constellation Pharmaceuticals
Nominating Committee Nathan A. Pennell 9/29/2020 Amgen Altor BioScience (Inst) AstraZeneca AstraZeneca (Inst) Bristol-Myers Squibb Bristol-Myers Squibb (Inst) Cota Healthcare Celgene (Inst) G1 Therapeutics Genentech (Inst) Genentech Heat Biologics (Inst) Inivata Jounce Therapeutics (Inst) Lilly Loxo (Inst) Merck Merck (Inst) Pfizer Mirati Therapeutics (Inst) Boehringer Ingelheim Pfizer (Inst) Viosera Spectrum Pharmaceuticals (Inst) WindMIL (Inst)